233 related articles for article (PubMed ID: 33050765)
1. Transarterial chemoembolization combined with iodine-125 seed implantation for patients with hepatocellular carcinoma: a retrospective controlled study.
Chen L; Sun T; Kan X; Chen S; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C
J Int Med Res; 2020 Oct; 48(10):300060520944309. PubMed ID: 33050765
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
Chen L; Kan X; Sun T; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C
BMC Gastroenterol; 2020 Jun; 20(1):205. PubMed ID: 32600349
[TBL] [Abstract][Full Text] [Related]
3. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
5. Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3-5cm: A propensity score matching study.
Li M; He J; Pan M; Yu Y; Pan Z; Xu B; Zhu J
Dig Liver Dis; 2016 Sep; 48(9):1082-7. PubMed ID: 27365224
[TBL] [Abstract][Full Text] [Related]
6. Integrated I-125 Seed Implantation Combined with Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus.
Wang W; Wang C; Shen J; Ren B; Yin Y; Yang J; Tang H; Zhu X; Ni C
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1570-1578. PubMed ID: 34117503
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
Lin LW; Yan LY; Ke K; Yang WZ; Lin JQ; Huang N
Brachytherapy; 2023; 22(6):858-871. PubMed ID: 37574351
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolization Followed by Radiotherapy Versus Sandwich Treatment for Unresectable or Ablative Hepatocellular Carcinoma.
Lin H; Wu H; Cong N; Liu B; Liu C; Han D
Technol Cancer Res Treat; 2020; 19():1533033820983799. PubMed ID: 33357168
[TBL] [Abstract][Full Text] [Related]
9. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
Guo W; Chen S; Wu Z; Zhuang W; Yang J
Technol Cancer Res Treat; 2020; 19():1533033820965587. PubMed ID: 33089769
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
[TBL] [Abstract][Full Text] [Related]
12. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY
J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study.
Aktas G; Kus T; Emin Kalender M; Kervancioglu S; Sevinc A; Kul S; Camci C
J BUON; 2017; 22(1):150-156. PubMed ID: 28365948
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
Huang M; Lin Q; Wang H; Chen J; Bai M; Wang L; Zhu K; Jiang Z; Guan S; Li Z; Qian J; Li M; Pang P; Shan H
Eur Radiol; 2016 Oct; 26(10):3428-36. PubMed ID: 26792430
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of (125)I radioactive seed implantation plus transcatheter arterial chemoembolization combined with radiofrequency ablation in treating patient with sub-capsular hepatocellular carcinoma].
Fang SJ; Gao RJ; Zheng LY; Zhao ZW; Fan XX; Song JJ; Zhang DK; Wu FZ; Ji JS
Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3853-3857. PubMed ID: 30585029
[No Abstract] [Full Text] [Related]
16. Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study.
Jiang N; Zhong B; Huang J; Li W; Zhang S; Zhu X; Ni C; Shen J
Front Immunol; 2023; 14():1205636. PubMed ID: 37583693
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study.
Chen YX; Zhang JX; Zhou CG; Liu J; Liu S; Shi HB; Zu QQ; Cheng Y
J Gastrointest Cancer; 2024 Jun; 55(2):924-931. PubMed ID: 38470522
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study.
Li H; Wang J; Zhang G; Kuang D; Li Y; He X; Xing C; Wang Y; Shi M; Han X; Ren J; Duan X
Front Immunol; 2023; 14():1277329. PubMed ID: 38090566
[TBL] [Abstract][Full Text] [Related]
19. Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC).
Lin XJ; Li QJ; Lao XM; Yang H; Li SP
BMC Cancer; 2015 Oct; 15():707. PubMed ID: 26470869
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
